Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology
Reference49 articles.
1. Administration UDoHaHSFaD (2012) Guidance for industry: enrichment strategies for clinical trials to support approval of human drugs and biological products.
http://www.fdagov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM332181pdf
. Accessed 12 Nov 2017
2. Balash Y et al (2017) Medical cannabis in Parkinson disease: real-life patients’ experience. Clin Neuropharmacol 40:268–272.
https://doi.org/10.1097/WNF.0000000000000246
3. Biaggioni I, Freeman R, Mathias CJ, Low P, Hewitt LA, Kaufmann H, Droxidopa I (2015) Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa. Hypertension 65:101–107.
https://doi.org/10.1161/HYPERTENSIONAHA.114.04035
4. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211
5. Brotchie JM (2003) CB1 cannabinoid receptor signalling in Parkinson’s disease. Curr Opin Pharmacol 3:54–61
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献